Nicholas is our Senior Vice President of Chemistry with more than 20 years of drug discovery experience in the pharmaceutical industry. Most recently at Seragon Pharmaceuticals and Aragon Pharmaceuticals, he was Vice President of Chemistry where he oversaw medicinal chemistry projects, including the development of two estrogen receptor degrader clinical candidates, and a next-generation androgen receptor antagonist program. In addition, Nicholas was responsible for the Aragon and then Seragon intellectual property portfolios and aspects of clinical manufacturing. Prior to Aragon, he was Head of Chemistry at Kalypsys Pharmaceuticals. Prior to Kalypsys, Nicholas was a Research Fellow at Merck & Co., where he led chemistry groups that contributed to clinical candidates in the areas of obesity and inflammation. Nicholas was a post-doctoral fellow at the University of Toronto and has a Ph.D. in synthetic organic chemistry from the University of Southampton, UK.